HAVCR2 and acute myeloid leukemia: In addition, a combination of PD-1high and TIM-3+ markers on T cells revealed that high levels of that subset were also associated with higher risk of AML relapse after transplantation of allo-SCT [33], due to the clear stratification of patients into CR and NR groups, we managed to highlight the role of PD-1 level within Th lymphocytes in AML subjects’ response to the therapy.